CMV retinitis screening and treatment in a resource-poor setting: Three-year experience from a primary care HIV/AIDS programme in Myanmar

Journal of the International AIDS Society

Volumn 14, Issue 1, 2011, Pages

  Tun, Nini ^a   London, Nikolas ^b   Kyaw, Moe ^c   Smithuis, Frank ^a   Ford, Nathan ^c,d   Margolis, Todd ^e   Drew, W Lawrence ^e   Lewallen, Susan ^f   Heiden, David ^g,h  

^a Medical Action Myanmar ^*  (Myanmar)

^b WILLS EYE HOSPITAL   (United States)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Kilimanjaro Centre for Community Ophthalmology   (Tanzania)

^g CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^h Seva Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; ANTIVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL COMPETENCE; CYTOMEGALOVIRUS RETINITIS; FEMALE; GENERAL PRACTITIONER; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MYANMAR; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; DEVELOPING COUNTRY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVITREAL DRUG ADMINISTRATION; MASS SCREENING; METHODOLOGY; NEGLECTED DISEASE; PRIMARY HEALTH CARE; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS RETINITIS; DEVELOPING COUNTRIES; FEMALE; GANCICLOVIR; HIV INFECTIONS; HUMANS; INTRAVITREAL INJECTIONS; MALE; MASS SCREENING; MYANMAR; NEGLECTED DISEASES; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80051594618     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-14-41     Document Type: Article

References (18)

1. Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. Heiden D, Ford N, Wilson D, Rodriguez WR, Margolis T, Janssens B, Bedelu M, Tun N, Goemaere E, Saranchuk P, Sabapathy K, Smithuis F, Luyirika E, Drew WL, PLoS Med 2007 4 12 334 10.1371/journal.pmed.0040334 18052600
2. Essential Prevention and Care Interventions for Adults and Adolescents Living with HIV in Resource-Limited Settings. HIV/AIDS Programme: Strengthening health services to fight HIV/AIDS Geneva: World Health Organization Department of HIV/AIDS 2008 1 110
3. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H, MMWR Recomm Rep 2009 58 RR-4 1 207 quiz CE201-204 19834454
4. Blindness and low vision in a tertiary ophthalmologic center in Thailand: the importance of cytomegalovirus retinitis. Pathanapitoon K, Ausayakhun S, Kunavisarut P, Wattananikorn S, Leeungurastien T, Yodprom R, Narongjunchai D, Rothova A, Retina 2007 27 5 635 640 10.1097/01.iae.0000249575.38830.45 17558328 (Pubitemid 46905157)
5. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. Manosuthi W, Chaovavanich A, Tansuphaswadikul S, Prasithsirikul W, Inthong Y, Chottanapund S, Sittibusaya C, Moolasart V, Termvises P, Sungkanuparph S, J Infect 2007 55 5 464 469 10.1016/j.jinf.2007.07. 002 17714788 (Pubitemid 47611502)
6. Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007). Micol R, Buchy P, Guerrier G, Duong V, Ferradini L, Dousset JP, Guerin PJ, Balkan S, Galimand J, Chanroeun H, Lortholary O, Rouzioux C, Fontanet A, Leruez-Ville M, J Acquir Immune Defic Syndr 2009 51 4 486 491 10.1097/QAI.0b013e3181a254c2 19421071
7. Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Holbrook JT, Jabs DA, Weinberg DV, Lewis RA, Davis MD, Friedberg D, Arch Ophthalmol 2003 121 1 99 107 12523893 (Pubitemid 36401774)
8. A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group. Spector SA, Weingeist T, Pollard RB, Dieterich DT, Samo T, Benson CA, Busch DF, Freeman WR, Montague P, Kaplan HJ, et al. J Infect Dis 1993 168 3 557 563 10.1093/infdis/168.3.557 8394858 (Pubitemid 23254272)
9. Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001. Yust I, Fox Z, Burke M, Johnson A, Turner D, Mocroft A, Katlama C, Ledergerber B, Reiss P, Kirk O, Eur J Clin Microbiol Infect Dis 2004 23 7 550 559 15232720 (Pubitemid 38998462)
10. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Ansari NA, Kombe AH, Kenyon TA, Hone NM, Tappero JW, Nyirenda ST, Binkin NJ, Lucas SB, Int J Tuberc Lung Dis 2002 6 1 55 63 11931402 (Pubitemid 34263546)
11. Ocular, cerebral and systemic interrelationships of cytomegalovirus infection in a post-mortem study of AIDS patients. Pecorella I, Ciardi A, Credendino A, Marasco A, Di Tondo U, Scaravilli F, Eye (Lond) 1999 13 Pt 6 781 785 (Pubitemid 30050509)
12. Global access to eye care. Sommer A, Arch Ophthalmol 2007 125 3 399 400 10.1001/archopht.125.3.399 17353413 (Pubitemid 46425570)
13. WHO/UNAIDS/UNICEF, Epidemiological Fact Sheet on HIV and AIDS: Core Data on Epidemiology and Response, Myanmar Geneva: UNAIDS/WHO 2008
14. Management of virus infections (cytomegalovirus, herpes simplex virus, varicella-zoster virus). Drew WL, Erlich KS, Global HIV/AIDS medicine New York: Elsevier, Volberding P, Sande M, Lange J, Greene W, Gallant J, 2007 437 461
15. Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Jacobson MA, N Engl J Med 1997 337 2 105 114 10.1056/NEJM199707103370207 9211681 (Pubitemid 27284397)
16. Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA). Binquet C, Saillour F, Bernard N, Rougier MB, Leger F, Bonnal F, Dabis F, Eur J Epidemiol 2000 16 5 425 432 10.1023/A:1007627508918 10997829
17. Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia J, Clin Infect Dis 2003 37 10 1365 1373 10.1086/379077 14583871 (Pubitemid 37433634)
18. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. Martin DF, Sierra-Madero J, Walmsley S, Wolitz RA, Macey K, Georgiou P, Robinson CA, Stempien MJ, N Engl J Med 2002 346 15 1119 1126 10.1056/NEJMoa011759 11948271 (Pubitemid 34984602)